Edap Tms (NASDAQ:EDAP – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect Edap Tms to post earnings of ($0.11) per share and revenue of $20.83 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.
Edap Tms Price Performance
EDAP stock opened at $2.26 on Thursday. The stock has a 50-day moving average price of $2.42 and a two-hundred day moving average price of $2.56. The stock has a market cap of $83.86 million, a PE ratio of -3.48 and a beta of 0.37. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. Edap Tms has a 1 year low of $2.00 and a 1 year high of $8.50.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on Edap Tms in a report on Wednesday, March 12th. They set a “hold” rating for the company.
About Edap Tms
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Read More
- Five stocks we like better than Edap Tms
- What Do S&P 500 Stocks Tell Investors About the Market?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 Best Fintech Stocks for a Portfolio Boost
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Invest in Small Cap Stocks
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.
